New blood test may spot liver cancer earlier in hepatitis c patients
NCT ID NCT07404566
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether measuring tiny molecules called microRNAs in the blood can help diagnose liver cancer (hepatocellular carcinoma) in people with hepatitis C. Researchers tested blood samples from 84 participants, including healthy people and those with hepatitis C, with or without liver cancer. They measured five specific microRNAs to see if they could accurately tell apart liver cancer from other liver conditions. The goal is to develop a more reliable screening tool than current blood tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PCR measurement of microRNA levels (MiR-21, 1246, 205, 29a-3p, 497) in blood
What this could lead to
If successful, this could lead to a simple blood test that detects liver cancer earlier and more accurately in people with hepatitis C.
What could go wrong
This is a small, completed study with 84 participants, so results may not apply to larger or different groups. The test is still experimental and not yet ready for routine use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alexandria Faculty of medicine
Alexandria, El Alexandria, 21512, Egypt